Ali Behbahani – Biographie

Ali était Partner chez New Enterprise Associates, et Director chez Crispr Therapeutics.

Ali Behbahani est actuellement

• Partner and Co-Head of Healthcare at Nea - View - Nea org chart

• Director at 858 Therapeutics - View - 858 Therapeutics org chart

• Director at Arcellx - View - Arcellx org chart

• Director at Black Diamond Therapeutics - View - Black Diamond Therapeutics org chart

• Director at Crispr Therapeutics - View - Crispr Therapeutics org chart

• Director at Korro Bio - View - Korro Bio org chart

• Director at Monte Rosa Therapeutics - View - Monte Rosa Therapeutics org chart

• Director at Nkarta Therapeutics - View - Nkarta Therapeutics org chart

• Director at Stablix Therapeutics - View - Stablix Therapeutics org chart

• Director at Tune Therapeutics - View - Tune Therapeutics org chart

• Non-Executive Director at Adaptimmune Therapeutics - View - Adaptimmune Therapeutics org chart

Créer une alerte
pour suivre le parcours de Ali Behbahani.

Ali Behbahani a obtenu un Medical Degree de University of Pennsylvania School of Medicine et un Master of Business Administration de University of Pennsylvania - The Wharton School.

Ils ont aussi étudié à University of Pennsylvania School of Medicine:

• Daniel Skovronsky - Eli Lilly

• Kristine Yaffe - Alector

• Katherine Reape - Akouos

Trouver d'autres anciens étudiants de University of Pennsylvania School of Medicine

Ils ont aussi étudié à University of Pennsylvania - The Wharton School:

• Elon Musk - Tesla
• Sundar Pichai - Google
• Alex Gorsky - Apple

Trouver d'autres anciens étudiants de University of Pennsylvania - The Wharton School

Voici quelques conseils pour établir rapidement un excellent contact.